Dejshontaye Would, who is also known as Dejshontaye Goddeszholliwould and Daryl Graves, has been in state custody since she ...

The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, uncontrolled and “true” treatment-resistant hypertension, according to data ...

The first openly transgender MMA fighter Fallon Fox has been a focal point in the ongoing debate about transgender athletes ...

The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...

The Hollywood leading man opens up about why he originally kept his wellness journey a secret—and why he's sharing more now.

A hormone specialist reveals her mission to change perceptions about menopause and enhance women's quality of life.

Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...

In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast ...

Gender-affirming hormone therapy in primary care is associated with lower rates of depressive symptoms in US transgender, nonbinary, and gender-diverse adults over 4 years of follow-up.

Legislation regulating the prescription of puberty blockers for transgender minors and banning use of the state insurance plan for gender-affirming care clear House panels.

The government of Queensland, Australia initiated Thursday an independent review into the use of paediatric gender hormone therapy. While the final report is due by 30 November 2025, the pause on ...

Transgender people receiving gender-affirming hormone therapy have a 37% lower chance of acquiring HIV, and for people living with HIV, hormone therapy appears to offer a 44% lower chance of the virus ...